AJCN North Carolina Research Campus
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     

This Article
Right arrow Full Text (PDF)
Right arrow Purchase Article
Right arrow View Shopping Cart
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Sugano, M.
Right arrow Articles by Hasegawa, Y.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Sugano, M.
Right arrow Articles by Hasegawa, Y.
Agricola
Right arrow Articles by Sugano, M.
Right arrow Articles by Hasegawa, Y.

American Journal of Clinical Nutrition, Vol 33, 787-793, Copyright © 1980 by The American Society for Clinical Nutrition, Inc

ORIGINAL RESEARCH COMMUNICATIONS

A novel use of chitosan as a hypocholesterolemic agent in rats

M Sugano, T Fujikawa, Y Hiratsuji, K Nakashima, N Fukuda and Y Hasegawa

A series of experiments with male rats clearly demonstrated the hypocholesterolemic activity of dietary chitosan. On feeding a high cholesterol diet for 20 days, addition of 2 to 5% chitosan resulted in a significant reduction, by 25 to 30%, of plasma cholesterol without influencing food intake and growth. The concentration of liver cholesterol and triglyceride also decreased significantly. Plasma, but not liver cholesterol-lowering effect, was roughly comparable with that of cholestyramine. Chitosan at the 10% level further reduced plasma cholesterol, but depressed growth. Also, finer chitosan particles tended to restrain growth even at the 2% level. In rats fed a cholesterol-free diet containing 0.5% chitosan for 81 days, the concentration of serum cholesterol was the same with that of the corresponding control, but relatively more cholesterol existed as high- density lipiproteins and less as very low-density lipoproteins. Dietary chitosan increased fecal excretion of cholesterol, both exogenous and endogenous, while that of bile acids remained unchanged. There was no constipation or diarrhea. A proper supplementation of chitosan to the diet seemed to be effective in lowering plasma cholesterol.


This article has been cited by other articles:


Home page
 The Annals of PharmacotherapyHome page
S.-S. Huang, S.-H. Sung, and C.-E. Chiang
Chitosan Potentiation of Warfarin Effect
Ann. Pharmacother., November 1, 2007; 41(11): 1912 - 1914.
[Abstract] [Full Text] [PDF]

Home page
 J. Am. Coll. Nutr.Home page
D. D. Gallaher, C. M. Gallaher, G. J. Mahrt, T. P. Carr, C. H. Hollingshead, R. Hesslink Jr, and J. Wise
A Glucomannan and Chitosan Fiber Supplement Decreases Plasma Cholesterol and Increases Cholesterol Excretion in Overweight Normocholesterolemic Humans
J. Am. Coll. Nutr., October 1, 2002; 21(5): 428 - 433.
[Abstract] [Full Text] [PDF]

Home page
 J. Nutr.Home page
C. M. Gallaher, J. Munion, R. Hesslink Jr., J. Wise, and D. D. Gallaher
Cholesterol Reduction by Glucomannan and Chitosan Is Mediated by Changes in Cholesterol Absorption and Bile Acid and Fat Excretion in Rats
J. Nutr., November 1, 2000; 130(11): 2753 - 2759.
[Abstract] [Full Text] [PDF]

Home page
 Journal of Bioactive and Compatible PolymersHome page
B. C. Benicewicz and P. K. Hopper
Review : Polymers for Absorbable Surgical Sutures--Part II
Journal of Bioactive and Compatible Polymers, January 1, 1991; 6(1): 64 - 94.
[PDF]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 1980 by The American Society for Nutrition